Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. - sprookjes - yvandenbroek - TriplyDB

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

http://www.wikidata.org/entity/Q33817011

about

Integrating cancer genomic data into electronic health records Implementing Genome-Driven Oncology.Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data Precision oncology: Charting a path forward to broader deployment of genomic profiling Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment.THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS.Therapy-related myeloid neoplasms: when genetics and environment collide.Germline genetic variants in men with prostate cancer and one or more additional cancers.Managing the genomic revolution in cancer diagnostics.Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.The future of clinical cancer genomics.Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.A novel molecular diagnostics platform for somatic and germline precision oncology.Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care.The impact of hereditary cancer gene panels on clinical care and lessons learned.Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma.Patient preferences regarding incidental genomic findings discovered during tumor profiling.Discussing the predictive, prognostic, and therapeutic value of germline DNA-repair gene mutations in metastatic prostate cancer patients.Concomitant ATM Mutations Identified by Next Generation Sequencing in a Patient With New-Onset Acute Myeloid Leukemia Following Imatinib Treatment for Chronic Myeloid Leukemia.Additional germline findings from a tumor profiling program Familial pancreatic cancer Counseling and Testing for Inherited Predisposition to Cancer

P2860

Q28077310-976B57FD-0A2E-4D29-8943-35138721ACD5 Q30235979-642CB4AE-F9EC-4AE4-960D-6B71EE1D0C4D Q31114379-6D0A909A-F4B0-4F52-B9E3-0560950EA936 Q31117752-5513EA34-2C62-421F-B67A-0F6EC7E3F99C Q31157014-30BB5B9F-FB67-4826-BA10-3951EB4B5251 Q33750026-3E8041A1-E11F-453D-93F1-4C9827AB0E87 Q36286293-DB57A6E4-FAC0-4602-998E-E5439394E01F Q36376718-3776203A-2C3F-4314-A1A1-C813516E1ACC Q36847816-D0A43977-2512-433E-9914-731CFE0D3596 Q37179254-945BE9CF-EF79-4713-9AC2-FB63E293DFE1 Q37311095-FF6EBBB8-0A17-4D2D-940C-88520EF8D12E Q37563869-A06F88F1-CD89-4132-B4CE-01DEC741D150 Q38611096-575F77F9-5F29-48FF-90FD-8BB2647B305A Q38705089-D18E50FA-4235-4317-86E6-6C824BDBC493 Q38714606-EDDFB166-DE21-4D04-83B6-131B3F897066 Q38719280-728A251B-0A75-4531-B7A0-5630032B26C5 Q38789283-FC58B0EB-892D-498B-996E-0CA16111A558 Q38798543-B902A1E3-8001-4FDA-A7ED-CFDBA293B875 Q38850529-A6DDC464-1E74-4C6A-82A4-57DA1D97D959 Q38904371-393DCC11-9895-421A-AC31-9F3C2CCEEF68 Q39847275-9B48EC7C-4080-4918-97F5-58CB6DF3CE53 Q40074639-BBCB7E66-05DE-4E11-98CD-47448BD9B764 Q40445128-B5200954-3111-4EE5-9929-8F8E13CED649 Q40568462-4CA6D7E7-A69C-4604-9802-BA9EDE14D01C Q40605505-BF4897BD-EFDF-4F5E-9B4A-4CA0FE83C5D5 Q41023790-42FE5F8F-189A-44CB-82A6-F02C98BA4400 Q46083971-1F4D1678-2482-46D0-AE11-33DDD603C038 Q47122725-2FE7A052-9E71-4FB7-909F-B6FFEA5E9D70 Q47157369-A0D5B6E2-62A4-4D0E-BE65-12AE19BED0E7 Q47713578-7641D4D0-3A55-436B-96AC-ECE88C6AB73B Q47768051-68BF0EA3-9A36-4B8B-AF2F-7844D312E485 Q50222046-BB84BE67-A5DD-4931-BAA8-B905FA228B30 Q50992753-8009E0A1-D450-48E8-B427-7F212692DF5C Q53149929-A94C89CA-13BD-4CAD-8DA5-E4BB9F9CE68B Q53178818-EC885371-1813-45BA-A317-43CC1E3C9D4D Q55359187-36BAEBA5-9DC7-4258-AF19-B446A2A77E42 Q57640179-52CACD10-7352-4CA0-80AE-6055D9136030 Q57643835-C537536E-9478-4A0F-A84D-F6236B8E24E3 Q57907570-5B3C25B5-337E-4A6A-9D78-5F23149AA501

P2860

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

http://www.wikidata.org/entity/Q33817011

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@ast

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@en

type

label

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@ast

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@en

prefLabel

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@ast

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@en

P1433

Q33817011-52B86C11-B45B-448D-9F50-3AF21A257B74

P1476

Q33817011-B11C335A-EEAB-4749-86EB-EE61EBBD4620

P2093

Q33817011-0AFEE43D-A01A-4E5A-BB81-CFA32F29EC13

Q33817011-2F92175A-9E36-43A7-BCEA-580B3099F933

Q33817011-3EC80D1E-666D-41AA-91C7-820D6ABEA1E7

Q33817011-44157F30-E4F0-458C-8D9D-4A88A0E30E1E

Q33817011-49A9EB7F-0D1F-40DC-9E53-56F13896DCC9

Q33817011-4F74A60B-F28C-429A-876D-4F0B514A6B0A

Q33817011-763DBE64-E9AC-4A52-8B1F-A270FD079813

Q33817011-7EB4C1EE-D6E5-4D0E-A6AF-EAAAA747BB9A

Q33817011-8244DDE1-D342-4E61-8C5A-A8D52715EE30

Q33817011-85E223A4-02A1-4D1A-858F-FE3F5BE08308

P2860

Q33817011-13722A87-6A36-4867-BE72-791F5016C2A0

Q33817011-30593B49-94C9-4FAC-BE2D-01278F2DFEBC

Q33817011-44B720E8-2679-4F2D-BFD0-B07D061ACA90

Q33817011-4A2FBCB0-1908-48FD-AE21-CEB8305DB2FD

Q33817011-4C91C4AE-ECAA-46B9-A000-623112A9A2A7

Q33817011-5847F49F-03E6-4D79-82B3-5935BD113F7D

Q33817011-6064827F-23CD-4D2C-8EF1-9EB99593C9BA

Q33817011-6BB3C42C-7ED7-4DAB-841A-BF75FD55EE3C

Q33817011-6EEFF440-4B9A-432F-9836-342EE538236E

Q33817011-7A443935-8658-4AA7-994C-1D9A6ACE5235

P304

Q33817011-D025116D-8BEB-4E1E-AFF2-519796A2A152

P31

Q33817011-747E3908-061A-4F99-9F5D-A23C09CE0CCF

P356

Q33817011-932EA8FE-8CBD-43C6-98A1-6D85DF7D6965

P433

Q33817011-EAF64DCB-FF8C-427C-A83E-FC1360163F91

P478

Q33817011-7E55B599-E599-4D81-97C7-8EEFE1820EDC

P50

Q33817011-09A9F1A2-BB48-41F7-9025-2F5879C635EF

Q33817011-1DD6B897-C779-4E28-BA4C-1CF5F769362B

Q33817011-5DB7931B-B2BA-417A-AD80-0989DC07B70E

Q33817011-DC918FAF-8F7E-4179-8385-4C2EF4A8EB36

P577

Q33817011-4AC7B2AA-16B1-4F6F-8903-C3404363B7F4

P698

Q33817011-2828B69C-7695-4BCA-AD82-FDA65427066F

P932

Q33817011-7F03BF34-A560-488D-B878-D78920E06F7C

P356

JAMAONCOL.2015.5208

P1433

P1476

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

@en

P2093

Ahmet Zehir

http://www.w3.org/2001/XMLSchema#string

Ai Ni

http://www.w3.org/2001/XMLSchema#string

Annie Lincoln

http://www.w3.org/2001/XMLSchema#string

Asad Ashraf

http://www.w3.org/2001/XMLSchema#string

David Klimstra

http://www.w3.org/2001/XMLSchema#string

David M Hyman

http://www.w3.org/2001/XMLSchema#string

David Solit

http://www.w3.org/2001/XMLSchema#string

Donavan T Cheng

http://www.w3.org/2001/XMLSchema#string

Liying Zhang

http://www.w3.org/2001/XMLSchema#string

Maria Arcila

http://www.w3.org/2001/XMLSchema#string

P2860

DELLY: structural variant discovery by integrated paired-end and split-read analysis

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

Age-related clonal hematopoiesis associated with adverse outcomes

Age-related mutations associated with clonal hematopoietic expansion and malignancies

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.

P304

104-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAONCOL.2015.5208

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Kasmintan A Schrader

P577

2015-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26556299

http://www.w3.org/2001/XMLSchema#string

P932

5477989

http://www.w3.org/2001/XMLSchema#string